Diltiazem Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Diltiazem Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

DILTIAZEM HYDROCHLORIDE DESCRIPTION


Diltiazem Hydrochloride









CLINICAL PHARMACOLOGY



Mechanism of Action




Hemodynamic and Electrophysiologic Effects





WARNINGS

Pharmacokinetics and Metabolism





INDICATIONS & USAGE




DILTIAZEM HYDROCHLORIDE CONTRAINDICATIONS



WARNINGS

ADVERSE REACTIONS


PRECAUTIONS

PRECAUTIONS

General

ADVERSE REACTIONS

DRUG INTERACTIONS

WARNINGSWARNINGS




WARNINGS






WARNINGS






CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY



PREGNANCY




NURSING MOTHERS



PEDIATRIC USE



GERIATRIC USE



DILTIAZEM HYDROCHLORIDE ADVERSE REACTIONS








WARNINGS, Acute Hepatic Injury




OVERDOSAGE













DOSAGE & ADMINISTRATION







WARNINGSPRECAUTIONS


HOW SUPPLIED







STORAGE AND HANDLING





PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Diltiazem Hydrochloride

Diltiazem Hydrochloride

Diltiazem Hydrochloride

Diltiazem Hydrochloride CAPSULE, EXTENDED RELEASE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-708(NDC:0228-2588)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
DILTIAZEM HYDROCHLORIDE DILTIAZEM 120 mg

Inactive Ingredients

Ingredient Name Strength
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2)
AMMONIA
FERROSOFERRIC OXIDE
GELATIN
hydroxypropyl cellulose
propylene glycol
SILICON DIOXIDE
SODIUM LAURYL SULFATE
SUCROSE
STARCH, CORN
talc
titanium dioxide
TRIETHYL CITRATE

Product Characteristics

Color Size Imprint Code Shape
gray 18 mm R;2588 CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-708-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA074984 2011-09-08


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.